Pfizer Consumer Business Not Critical During “Transition” Year
This article was originally published in The Tan Sheet
Executive Summary
Pfizer does not consider its consumer business to be key to the company's strategic outlook during the 2005 "transition" year, CEO Hank McKinnell indicated during an April 5 business review with analysts
You may also be interested in...
Pfizer Eyes Consumer Unit Spin-Off Or Sale Price North of $10 Bil.
Pfizer has "no interest" in separately divesting individual products from its consumer division, CEO Hank McKinnell said during a Feb. 10 analysts presentation
Pfizer Eyes Consumer Unit Spin-Off Or Sale Price North of $10 Bil.
Pfizer has "no interest" in separately divesting individual products from its consumer division, CEO Hank McKinnell said during a Feb. 10 analysts presentation
Pfizer Eyes Consumer Unit Spin-Off Or Sale Price North of $10 Bil.
Pfizer has "no interest" in separately divesting individual products from its consumer division, CEO Hank McKinnell said during a Feb. 10 analysts presentation